Is your organization missing from this list? Reach out to Leyla Cakici, Strategic Alliance Partnership Coordinator, to learn more about the complimentary strategic partnership program: lcakici@mjhlifesciences.com
OS With Chemotherapy Is Linked With Baseline Geriatric, QOL Factors in Metastatic Pancreatic Cancer
Bezuclastinib Plus Sunitinib Elicits Preliminary Activity, Is Safe in Pretreated GIST
Post-Chemotherapy ctDNA Status May Support Organ Preservation Decisions in Rectal Cancer
Adagrasib/Cetuximab Maintains Efficacy in KRAS G12C–Mutated Advanced mCRC